This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline Intellectual Property Development Limited. Active years: 2021-2026.
Company Filing History:
2 out of 545 
1 out of 242 
Years Active: 2021-2026
Title: The Innovations of Joel Karpiak
Introduction
Joel Karpiak is an accomplished inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of NRF2 activators. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Karpiak holds a patent for "Bisaryl amides as NRF2 activators." This invention relates to bisaryl amide analogs, pharmaceutical compositions containing them, and their use as NRF2 activators. The invention specifically focuses on bisaryl heterocycles of Formula (I), showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Joel Karpiak has been associated with GlaxoSmithKline Intellectual Property Development Limited. His role in this esteemed company has allowed him to work on groundbreaking projects that aim to improve health outcomes through innovative drug development.
Collaborations
Karpiak has collaborated with notable colleagues, including James Francis Callahan and Vincent J. Colandrea. These partnerships have fostered a collaborative environment that enhances the creative process and leads to successful innovations.
Conclusion
Joel Karpiak's contributions to the field of pharmaceuticals through his patent on NRF2 activators exemplify his dedication to innovation. His work continues to impact the industry positively, paving the way for future advancements in medical science.